This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Amit Taneja
Introduction
Amit Taneja is a notable inventor based in Haryana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new intermediates and processes for preparing Ticagrelor. His work exemplifies the intersection of innovation and practical application in medicine.
Latest Patents
Amit Taneja holds a patent for "Intermediates and processes for preparing Ticagrelor." This invention relates to new intermediates and processes that enhance the preparation of Ticagrelor, a medication used to reduce the risk of heart attacks and strokes. One of the embodiments of his invention provides a process for preparing Ticagrelor of Formula I, which involves coupling a compound of Formula VI with a compound of Formula IX.
Career Highlights
Amit Taneja is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role at Teva highlights his commitment to advancing pharmaceutical research and development. With a focus on innovative solutions, he has contributed to the company's mission of improving patient outcomes through effective medications.
Collaborations
Amit Taneja has worked alongside talented colleagues, including Vinod Kumar Kansal and Dhirenkumar Natvarial Mistry. Their collaborative efforts in the pharmaceutical field have fostered an environment of innovation and shared expertise.
Conclusion
Amit Taneja's contributions to the field of pharmaceuticals, particularly through his patent on Ticagrelor, showcase his dedication to innovation and improving healthcare. His work continues to impact the industry positively, reflecting the importance of research and development in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
